Remestemcel-L Completed Phase 2 Trials for Type 1 Diabetes Mellitus / Diabetes Mellitus, Insulin Dependent Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00690066PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)